page

While the science grounds us, our work is fueled by our passion for patients, a core value Syndax leads with and a conviction that runs deep throughout our organization. 

A mother joyfully holding her daughter, both smiling against a cloudy sky.

Our Products

Patients & Care Partners

Healthcare Providers

U.S. Prescribing Information Including Patient Information

Please see Full Prescribing Information, including BOXED WARNING <a style="color: #ce0037;" href="https://cms.syndax.com/revuforj-full-prescribing-info/" target="_blank" rel="noopener">here</a>.
<hr style="border-top: 1px solid #038095; margin: 12px 0 12px 0;" />
To report an adverse event or product quality complaint for Revuforj® (revumenib), or to request additional medical information, contact <a style="color: #ce0037;" href="mailto:medinfo@syndax.com">medinfo@syndax.com</a> or call 1-888-539-3REV (3738), option 1

FDA-Approved Medications

Talk with your Healthcare Team to learn more about program enrollment. Visit <a style="color: #ce0037;" href="https://www.syndaccess.com" target="_blank" rel="noopener">SYNDACCESS.COM</a> or call us to learn more: 1-888-567-SYND (7963) Monday &#8211; Friday, 9AM-6PM ET.

Healthcare  Providers

Niktimvo logo featuring the name in purple with a circular design element.

Please see Full Prescribing Information for Niktimvo™ <a style="color: #ce0037;" href="http://www.niktimvohcp.com/pdf/prescribing-information.pdf" target="_blank" rel="noopener">here</a>.
<hr style="border-top: 1px solid #038095; margin: 12px 0 12px 0;" />
You may report side effects for Niktimvo™ (axatilimab-csfr) to FDA at 1-800-FDA-1088. You may also report side effects to Incyte Corporation at 1-855-463-3463.

Our Products

FDA-Approved Medications

SyndAccess™ Patient Support Program*